Xtant Medical Holdings, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 0.2802 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 39.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
Details
| Name | Xtant Medical Holdings, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 151 |
| Ceo | Sean Browne |
| Country | United States |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US98420P3082 |
| Cusip | 98420P308 |
| Cik | 0001453593 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Sean E. Browne | President, Chief Executive Officer and Director |
| Scott C. Neils | Chief Financial Officer |
| Mark A. Schallenberger | Chief Operations Officer |
| Catherine Lundy | Vice President of Human Resources |
Contact
| Address | 664 Cruiser Lane, Belgrade, Montana 59714, United States |
| Phone | 406 388 0480 |
| Website | https://xtantmedical.com |